10.3 EUROPE TABLE 9 REAL WORLD EVIDENCE SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS TABLE 126 ASIA PACIFIC: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) 6.3 ECOSYSTEM ANALYSIS Directly accessible data for 170 industries from 50 countries and over 1 million facts: Get quick analyses with our professional research service. TABLE 84 GERMANY: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) 10.4.2.1 Low cost of clinical trials and large pharmaceutical R&D base in China to drive market growth The growth of this market is driven by factors such as the rising prevalence of chronic diseases, rapidly growing big data in healthcare, the shift from volume to value-based care, and the 13.3 CUSTOMIZATION OPTIONS Over the next five years up to 2025,. 7.1 INTRODUCTION The market is projected to grow from USD 271.83 billion in 2022 to USD 655.53 billion by 2029, exhibiting a CAGR of 13.4% during the forecast period. RWE is regularly utilized in the drug development & approval process to inform aspects of drug development, such as the natural history and epidemiology of a disease, and provide data on treatment pathways and comparator interventions in clinical practice. TABLE 103 ITALY: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) With this acquisition, the company aimed to strengthen its software portfolio through automation, data, and AI in order to address the full spectrum of observability.Nov-2021: PerkinElmer unveiled PKeye, a workflow monitor platform for remotely managing and monitoring workflows. 7.3.1.2 Claims data set Pune, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Real-world evidence is clinical evidence produced from information about the usage and possible advantages and disadvantages of a medical product (RWE).. TABLE 137 CHINA: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) A series of well-publicized recalls, and regulatory settlements have left policymakers and consumers questioning the safety of medical products and their trust in manufacturers. RWE data is needed for new drugs to successfully pass through clinical phases. FIGURE 47 IBM CORPORATION: COMPANY SNAPSHOT (2021) TABLE 114 REST OF EUROPE: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) The world's patient population is experiencing a rapidly increasing frequency of drug shortages whereby patients cannot get access to the medicines they critically need. FIGURE 17 SUPPORT FROM REGULATORY BODIES FOR THE USE OF RWE SOLUTIONS IS A MAJOR FACTOR DRIVING THE MARKET GROWTH The figures prior to 2020 are based on IDC's forecast from late 2018. on February 23, 2023 By Marcus Lu Retail Investors' Most Popular Stocks of 2023 (YTD) According to VandaTrack, retail investors are still a force to be reckoned with, adding an average of $1.5 billion each day into U.S. markets. The use of computers, mobile devices, wearables and other biosensors to gather and store huge amounts of health-related data has been rapidly accelerating. 80% of fortune 2000 companies rely on our research to identify new revenue sources. FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION The absence of universally accepted standards or principles that can be used for designing, analyzing, and reporting RWE has become a major challenge in this market. 8.3.1 INCREASING RESEARCH IN MEDICAL DEVICE DEVELOPMENT TO DRIVE DEMAND The interactive data tools below provide a way to explore public data from the 2022 EPA Automotive Trends Report. FIGURE 12 DISPARATE DATA SETS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) This research study involved the extensive use of both primary and secondary sources. 2.5 ASSUMPTIONS FOR THE STUDY 12.1.13 TRINETX LLC . - 198) The listing agent for these homes has added a Coming Soon note to alert buyers in advance. The big data analytics market is set to reach $103 billion by 2023. For our commercial pharma clients we integrate their commercial datasets such as ex-factory, in market sales and activity data. TABLE 31 INTEGRATED DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION), 8 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION (Page No. TABLE 112 SPAIN: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 33 REAL WORLD EVIDENCE SOLUTIONS MARKET IN DRUG DEVELOPMENT AND APPROVALS, BY TYPE 20202027 (USD MILLION) Available: https://www.statista.com/statistics/871513/worldwide-data-created/, Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025, Available to download in PNG, PDF, XLS format, Global IT spending forecast 2012-2023, by segment, IT spending year-over-year growth worldwide 2016-2023, by segment, Worldwide storage revenue growth 2017-2027, Worldwide storage spending per employee 2016-2028, Information archiving solutions market size worldwide 2014-2026, Amount of data created, consumed, and stored 2010-2020, with forecasts to 2025, Worldwide data storage unit revenue 2014-2027, Worldwide data storage unit revenue growth 2015-2027, Sales volume of data storage units worldwide 2014-2027, Data storage units volume growth worldwide 2015-2027, Per unit price of data storage units worldwide 2014-2027, DRAM market revenue worldwide 2010-2022, by quarter, NAND flash market revenue worldwide 2010-2022, by quarter, Market revenue from external enterprise storage systems 2009-2021, by quarter, NAND flash manufacturers revenue worldwide 2010-2022, by quarter, Enterprise external storage systems factory revenue worldwide 2009-2021, by quarter, Enterprise external storage systems vendor market share 2008-2021, by quarter, Spending on cloud and data centers 2009-2021, by segment, Share of IT infrastructure spending worldwide 2014-2024, by deployment type, Worldwide enterprise cloud strategy 2017-2022, Global unstructured data storage repositories used 2021, Global cloud storage security issues 2020-2021, by organization size, Global cloud identity and access management issues 2020-2021, by organization size, Smart building data volume collected globally 2010-2020, Data economy's impact on GDP in EU and UK 2018-2025, Number of data users in the EU and UK 2016-2020 and 2025, Data companies' revenues in the EU and UK 2016-2020 and 2025, Internet data consumption in Asia Pacific 2015-2020 by selected countries, Total Enterprise datasphere size by industry worldwide 2018, Internet data consumption in Indonesia 2013-2020, Internet data consumption in China 2013-2020, Value of data economy in EU and UK 2016-2020 and 2025, Average data consumption per user in one quarter in Indonesia 2019, Data as a share of total mobile service revenue in China 2004-2014, Mobile data as share of total telecom revenue in the United Kingdom (UK) 2004-2014, Monthly mobile data consumption volume by SIM card in France 2008-2017, All-flash array price in Taiwan Q3 2016-Q3 2018, Visual data room market value worldwide 2018-2027, Distribution of smartphone contracts with major providers Japan 2020, by data volume, Number of data professionals in the U.S. 2016-2020, Number of data professionals in the EU and UK 2016-2020 and 2025, Distribution of budget SIM cards for smartphones Japan 2020, by data volume, Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025 (in zettabytes), Find your information in our database containing over 20,000 reports. With this partnership, the company aimed at expanding Parexels network of real-world data (RWD) sources to deliver drug development solutions for customers. 11.8.4 DYNAMIC COMPANIES This lack of consensus has led to a situation where RWE lacks the quality to be part of the body of evidence used to determine the comparative effectiveness of different treatment options. Similarly, RWE can accelerate label expansion and decrease the overall cost of the evidence needed for filing. You only have access to basic statistics. Poor data quality costs the US economy up to $3.1 trillion yearly. For instance, in May 2020, PAREXEL International Corporation (U.S.) launched the #KeepingPatientsFirst integrated real-world evidence (RWE) research platform focused on aggregating, analyzing, and predicting real-world COVID-19-related disease progression and outcomes using state-of-the-art machine learning, artificial intelligence, and analytics. 12.1.15 PERKINELMER INC. RWD has been used increasingly to map the progression of the disease and to discover vaccines and immediate treatments. Note 2: Other primaries include sales managers, marketing managers, and product managers. 10.5.1 INCREASED HEALTHCARE EXPENDITURE TO SUPPORT MARKET GROWTH FIGURE 6 MARKET SIZE ESTIMATION: SEGMENTAL EXTRAPOLATION 1.4 LIMITATIONS TABLE 145 INDIA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) TABLE 19 CLINICAL SETTINGS DATA SETS OFFERED BY KEY MARKET PLAYERS TABLE 12 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) 5.2.3.2 Rise in focus on end-to-end RWE services TABLE 70 CANADA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) Real-world evidence (RWE) is clinical evidence gathered via RWD analysis on the use and potential benefits or risks of a medical product. The study categorizes the global real world evidence solutions market based on component, application, end user at regional/country and global level. The process of drug development requires evidence on population size, clinical disease progression, and adherence to similar therapies that can support decision-making. RWD can come from a number of sources, for example: Real-world evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of RWD. The global big data market in terms of revenue was estimated to be worth $162.6 billion in 2021 and is poised to reach $273.4 billion by 2026, growing at a CAGR of 11.0% from 2021 to 2026. 6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 7.3.1.1 Clinical settings data set By clicking Accept all you agree that Yahoo and our partners will process your personal information, and use technologies such as cookies, to display personalised ads and content, for ad and content measurement, audience insights, and product development. Furthermore, it would enable the company to bring new therapies to market by leveraging these studies.Sep-2018: PAREXEL came into partnership with Datavant, a healthcare technology company focused on enabling the secure de-identification and linking of healthcare datasets. 4.4 REGIONAL MIX: REAL WORLD EVIDENCE SOLUTIONS MARKET (20222027) TABLE 39 DRUG DEVELOPMENT AND APPROVALS MARKET IN IMMUNOLOGY, BY COUNTRY, 20202027 (USD MILLION) TABLE 154 LATIN AMERICA: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) As of December 1, 2022, there was nearly one job opening for every active applicant on LinkedIn. To define, describe, and forecast the real world evidence solutions market on the basis of components, application, end user, and region, To provide detailed information about the factors influencing the market growth (such as drivers, restraints, challenges, and opportunities), To strategically analyze micromarkets1 with respect to the individual growth trends, prospects, and contributions to the overall real world evidence solutions market, To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players. EMERGING MARKETS TABLE 78 EUROPE: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) 6.7.3.1 China R&D is very important in the pharmaceutical business in particular. U.S. FIGURE 15 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) TABLE 102 ITALY: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) FIGURE 56 PERKINELMER INC.: COMPANY SNAPSHOT (2021) TABLE 2 RISK ASSESSMENT: REAL WORLD EVIDENCE SOLUTIONS MARKET Thus, aiding in the dismantling of traditional silos and enabling insight-driven decision-making from the product R&D stage to its commercialization. Most pharmaceutical, biopharmaceutical, and medical device companies continue to invest heavily in the development of novel drugs and devices. TABLE 53 NORTH AMERICA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 5.2.1.3 Potential of RWE in reducing drug development costs and expediting the drug development process RWE helps and provides a means for demonstrating value, ranging from confirming randomized trial benefits in real-world populations to a fuller characterization of resource impacts. It is the process of using data to generate revenue or create new revenue-generating streams. TABLE 155 LATIN AMERICA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 18 DISPARATE DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) TABLE 67 CANADA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Users can now filter, sort and download two data types: Summary Automotive Trends Data. The global data monetization market size was valued at USD 1.30 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 24.1% from 2020 to 2027. Insurance. 10.2.2.1 Growing number of clinical trials in Canada to drive market growth (Business Overview, Products, Recent Developments, MnM View)* One of its mandates was for the US FDA to develop a framework to evaluate how data from sources other than clinical trials can be used to support drug approvals. TABLE 190 MEDPACE HOLDINGS INC.: BUSINESS OVERVIEW Purpose: There is a need to develop hybrid trial methodology combining the best parts of traditional randomized controlled trials (RCTs) and observational study designs to produce real-world evidence (RWE) that provides adequate scientific evidence for regulatory decision-making. TABLE 167 REAL WORLD EVIDENCE SOLUTIONS MARKET: DETAILED LIST OF SMALL & MEDIUM PLAYERS The worldwide market size of BI & analytics software applications could reach $17.6 billion by 2024. 6.4.3 BARGAINING POWER OF BUYERS TABLE 115 REST OF EUROPE: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 4.3 RWE SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES Government. TABLE 87 UK: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) TABLE 28 REGISTRY-BASED DATA SETS OFFERED BY KEY MARKET PLAYERS . The fast growth of pharmaceutical and medical device companies can be attributed to the increasing importance of RWE studies in drug approvals, the prevention of costly drug recalls, and the assessment of drug performance in real-world settings. The key factors. FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS TABLE 77 EUROPE: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) 5.2.4 CHALLENGES TABLE 45 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) TABLE 156 LATIN AMERICA: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) In 2021, the market access & reimbursement/coverage decisions segment accounted for the largest share of the overall real-world evidence solutions market. The growth of this market is primarily driven by the increasing growth in clinical trials and the shift from volume-based to value-based care. DownloadFree Sample Report Now @https://www.meticulousresearch.com/download-sample-report/cp_id=4954. from 8 AM - 9 PM ET. 1.2.1 INCLUSIONS AND EXCLUSIONS 5.2.4.1 Lack of universally accepted methodology standards and data processing infrastructure . According to Molex's latest survey: "Design Engineer Tell-All: Advancing Innovation in an Era of Disruption," evolving design processes, heightened customer expectations and persistent supply chain constraints are impacting global engineers in equal measure. FIGURE 58 CLINIGEN: COMPANY SNAPSHOT (2021) 10.3.1 GERMANY TABLE 130 JAPAN: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. 6.1.1 EMERGING ROLE OF WEARABLE DEVICES TABLE 73 EUROPE: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION)
As a Premium user you get access to background information and details about the release of this statistic. In addition, with the development of sophisticated, new analytical capabilities, we are better able to analyze these data and apply the results of our analyses to medical product development and approval. TABLE 188 CEGEDIM HEALTH DATA: BUSINESS OVERVIEW Data marketplaces and exchanges provide single platforms to consolidate third-party data offerings. - 98) Thus, stakeholders are reluctant to utilise evidence lacking a standard data generation procedure. * The data was taken from various publications released over several years: Forecast for the years 2018 and 2019 as of 2018; Forecast for 2020 as of May 2021; Forecast for 2021 to 2025 as of March 2021 based on figure for 2020 provided by the source. 10.4.2 CHINA 6.1.2 SOCIAL MEDIA-SOURCED RWE [Online]. TABLE 37 DRUG DEVELOPMENT AND APPROVALS MARKET IN CARDIOVASCULAR DISEASE, BY COUNTRY, 20202027 (USD MILLION) TABLE 113 SPAIN: RWE MARKET, BY END USER, 20202027 (USD MILLION) FIGURE 22 RWE SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES TABLE 153 REST OF ASIA PACIFIC: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) 11.8.3 RESPONSIVE COMPANIES FIGURE 31 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR RWE SOLUTIONS, 20162021 8.2.2.1 High prevalence of CVD to drive growth Many medical professionals and pharmaceutical companies have used their resources to stop the COVID-19 pandemics spread and create efficient drugs and vaccinations. As a Premium user you get access to the detailed source references and background information about this statistic. Among all industry sectors, the pharmaceutical industry spends the largest percentage of its revenue on research and development. FIGURE 28 ECOSYSTEM COVERAGE: RWE SOLUTIONS MARKET Various factors affecting the industry were studied to identify the segmentation types, industry trends, key players, competitive landscape of different solutions provided by market players, key player strategies, and key market dynamics, such as drivers, restraints, opportunities, and challenges. 11.2 STRATEGIES ADOPTED BY KEY PLAYERS /RIGHT TO WIN In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. FIGURE 16 REAL WORLD EVIDENCE SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT, 4 PREMIUM INSIGHTS (Page No.
The RWE Solutions Market is expected to grow at a CAGR of 11.8% from 2022 to 2029 to reach $4.93 billion by 2029. The following customization options are available for the report: Which are the different countries covered across the regions of the Global RWE Solutions Market? Looking forward, IMARC Group expects the market to reach US$ 2.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.57% during 2023-2028. To know about the assumptions considered for the study, download the pdf brochure. TABLE 76 EUROPE: RWE MARKET, BY APPLICATION, 20202027 (USD MILLION) For example, the role of RWE in drug development is expanding as RWE studies are significantly less costly and time-consuming than RCTs, providing easier access to long-term effectiveness data and helping overcome some of the feasibility barriers of running RCTs. 10.2 NORTH AMERICA 8.5 MARKET ACCESS AND REIMBURSEMENT/COVERAGE DECISION MAKING TABLE 99 FRANCE: RWE MARKET, BY END USER, 20202027 (USD MILLION) FIGURE 21 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD, 5 MARKET OVERVIEW (Page No. Healthcare Providers. These marketplaces and exchanges provide centralized availability and access (to X analytics and other unique data sets, for example) that create economies of scale to reduce costs for third-party data. The pressures are more significant in the oncological department, where high-cost agents with similar effects compete in the market. TABLE 160 MIDDLES EAST & AFRICA: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) 9.5 OTHER END USERS 2.4 MARKET RANKING ANALYSIS The desire to drastically accelerate R&D, reinforced by a greater understanding of data science, has made the healthcare community more receptive to expanding the use of RWE beyond traditional safety-related applications. TABLE 40 DRUG DEVELOPMENT AND APPROVALS MARKET IN OTHER THERAPEUTIC AREAS, BY COUNTRY, 20202027 (USD MILLION) 11.8 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES TABLE 128 JAPAN: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION)
The partnership is intended to pair the extensive experience of Bain & Company (US) in the Life Sciences value chain with the evidence-based solutions of Trinity Life Sciences (US). FIGURE 18 JAPAN ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 10.1 INTRODUCTION 12.2.2 DATAVANT - 28) The global Big Data market size is expected to reach from USD 157.9 billion in 2020 to USD 268.4 billion by 2026, at a CAGR of about 12% over the forecast period. 6.5.1 AVERAGE SELLING PRICE Pharma data analyses extract insights, inform new strategies and provide KPI tracking. Pharmaceutical and biotech companies are increasingly utilizing real-world evidence for collecting real-time post-trial information about drugs, which helps healthcare providers and researchers understand the negative reactions, side effects, and medication errors related to the drugs, thereby enabling them to control the potential harm caused by the drugs. TABLE 85 GERMANY: RWE MARKET, BY END USER, 20202027 (USD MILLION) Accessed March 02, 2023. https://www.statista.com/statistics/871513/worldwide-data-created/, IDC, and Statista. 9.1 INTRODUCTION The primary sources from the demand side included Directors, and strategy managers of pharmaceutical and medical device companies, insurance providers, healthcare providers, and department heads. FIGURE 38 ANNUAL DRUG APPROVALS BY CDER (FDA), 20112021 12.1.6 PAREXEL INTERNATIONAL CORPORATION
7.2 SERVICES TABLE 161 MIDDLES EAST & AFRICA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Science and Research Special Topics, Recalls, Market Withdrawals and Safety Alerts, Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products, Submitting Documents Using Real-World Data and Real-World Evidence to FDA for Drug and Biological Products, Framework for FDAs Real-World Evidence Program, Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products, Assessing Registries to Support Regulatory Decision-Making for Drug and Biological Products, Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products, Data Standards for Drug and Biological Product Submissions Containing Real-World Data, Submitting Documents Utilizing Real-World Data and Real-World Evidence to FDA for Drugs and Biologics, Use of Electronic Health Records in Clinical Investigations, Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices. Additionally predicted to drive market growth is rising consumer desire for better healthcare services.The market research report covers the analysis of key stake holders of the market. (IDC, 2020) $72.8 billion - the projected worldwide AR/VR market size in 2024. To use individual functions (e.g., mark statistics as favourites, set United States Real-World Evidence (RWE) Solutions Market Report 2022: Market is Expected to Grow at a CAGR of 13% from 2021 to 2028 to Reach $2.01 Billion by 2028 - ResearchAndMarkets.com March 11 . Profit from the additional features of your individual account. 12.2.5 FLATIRON HEALTH, 13 APPENDIX (Page No. The Global Real World Evidence Solutions Market size is The Global Real World Evidence Solutions Market size is expected to reach $65.1 billion by 2028, rising at a market growth. 10.3.2 UK (IDC, 2020) TABLE 118 REST OF EUROPE: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) 12.2.3 SYAPSE INC. Real-world evidence (RWE) is the clinical evidence about the usage and potential benefits or risks of a medical product derived from analysis of RWD. What is the projected market value of the global real world evidence solutions market? FIGURE 53 ORACLE CORPORATION: COMPANY SNAPSHOT (2021) The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. The global real world evidence solutions market size was valued at USD 42.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2030. 10.3.4 ITALY TABLE 35 DRUG DEVELOPMENT AND APPROVALS MARKET IN ONCOLOGY, BY COUNTRY, 20202027 (USD MILLION) TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD FDA Announces New Funding Opportunity for Using Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making, FDA Issues Draft Guidances on Real-World Evidence, Prepares to Publish More in Future, FDA Clinical Investigator Training Course, Real-World Evidence- Dec 2021, FDA Approves New Use of Transplant Drug Based on Real-World Evidence, FDA Announces 4 Grant Awards for Projects Exploring the Use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making, CDER Small Business and Industry Assistance Webinar: Framework for FDAs Real-World Evidence Program - Mar 15, 2019, CDERMedicalPolicy-RealWorldEvidence@fda.hhs.gov. 5.2.1 DRIVERS Note 3: Companies are classified into tiers based on their total revenue. Please create an employee account to be able to mark statistics as favorites.